Fine Foods Limited (DSE:FINEFOODS)
506.30
+15.00 (3.05%)
At close: Apr 28, 2026
Fine Foods Revenue
Fine Foods had revenue of 43.85M BDT in the quarter ending December 31, 2025, with 20.46% growth. This brings the company's revenue in the last twelve months to 155.48M, up 59.67% year-over-year. In the fiscal year ending June 30, 2025, Fine Foods had annual revenue of 118.90M with 61.98% growth.
Revenue (ttm)
155.48M
Revenue Growth
+59.67%
P/S Ratio
45.50
Revenue / Employee
1.31M
Employees
119
Market Cap
7.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 118.90M | 45.50M | 61.98% |
| Jun 30, 2024 | 73.40M | 11.79M | 19.13% |
| Jun 30, 2023 | 61.62M | 1.61M | 2.68% |
| Jun 30, 2022 | 60.01M | 1.05M | 1.77% |
| Jun 30, 2021 | 58.96M | -1.52M | -2.51% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| City Insurance PLC. | 914.23M |
| ACI Formulations | 5.52B |
| Pragati Life Insurance | 6.82B |
| Pioneer Insurance | 2.07B |
| Orion Infusion | 665.43M |
| Navana Pharmaceuticals | 10.07B |
| Orion Pharma | 3.12B |
| One Bank | 7.30B |